The Merger's Tangled Web

Gerson Bakar
Chairman, Gerson Bakar & Associates

T. Robert Burke
AMB Institutional Realty Advisors

Donald Fisher
Chairman, The Gap Inc.

John Larson
Chairman/attorney, Brobeck, Phelger & Harrison LLP

Sanford Robertson
Chairman, Robertson Stephens & Co. venture capital firm
Invest in medical technology, biotechnology, and medical services

William Rutter
Chairman, Chiron Corp. pharmaceutical company

Llyod Smith
Professor, UCSF

USHC Board of Directors
Directors of the new, nonprofit corporation formed in anticipation of the merger of University of California, San Francisco and Stanford University medical centers.

Richard Atkinson (UC)
President, University of California
Stockholder, DepoTech Corp. and other pharmaceutical interests

Eugene Bauer (Stanford)
Dean, Stanford University School of Medicine

Richard Behrman (independent)
Managing director, Center for the Future of Children, David and Lucille Packard Foundation

Gerhard Casper (Stanford)
President, Stanford University

Haile Debas (UCSF)
Chancellor, University of California, San Francisco

Tirso del Junco (UC)
Surgeon

Lee Goldman (UCSF)
Chair and professor of medicine, University of California, San Francisco

F. Warren Hellman (independent)
General partner, Hellman & Friedman investment firm
Director, American President Lines Inc.
Former director, UCSF Foundation

Howard Leach (UC)
Investor, Leach Capital

Woodrow Myers Jr. (SHS)
Director of health care management, Ford Motor Co.

Denise O'Leary (SHS)
Director, Alza Corp. pharmaceutical company
Director, Western Association of Venture Capitalists
Former general partner, Menlo Ventures

Richard Rosenberg (independent)
Retired CEO, BankAmerica Corp., Mastercard International

Isaac Stein (SHS)
President, Waverly Associates
Director, Alza Corp., CV Therapeutics pharmaceutical companies

Judith Swain (Stanford)
Chair and professor of medicine, Stanford University School of Medicine

Open seat (UCSF)
School of Medicine

Stanford Health Services Board of Directors
The merger requires approval from both the UC Board of Regents and the Stanford Health Services Board.

Eugene Bauer
Dean, Stanford University School of Medicine

Richard Behrman
Managing director, Center for the Future of Children, David and Lucille Packard Foundation

Peter Bing
Doctor, Los Angeles

Gerhard Casper
President, Stanford University

LaDoris Cordell
Judge, Santa Clara County Superior Court

Gary Glazer
Director, National Cancer Institute training program, Dept. of Radiology

Peter Gregory
Senior associate dean for clinical affairs

Robert Halperin
Former CEO, Raychem Corp.
Consultant, Greylock Management Corp.
Director, Avid Technology pharmaceutical company

John Kelly
Investor

John Lillie
Former chairman, American President Lines Inc.
Director, The Gap Inc.

Ernest Mario
CEO, Alza Corp.

Linda Meier
Fund-raiser
Director, Peninsula Community Foundation

Malinda Mitchell
Acting president

Woodrow Myers
Director of health care management, Ford Motor Co.

Denise O'Leary
Former general partner, Menlo Ventures
Director, Alza Corp. pharmaceuticals

John Scully
Partner, SPO Partners investment firm

Isaac Stein
Founding partner, Waverly Associates investment firm, Palo Alto
Director, Alza Corp.; CV Therapeutics

Committee to name the outside directors of USHC board
This group was chosen by the UCSF and Stanford presidents to select the three outside directors to the nonprofit board.

William Coblentz
Attorney, Coblentz, Cahen, McCabe & Breyer

Donald Fisher
Chairman, The Gap Inc.

Robert Halperin
Former CEO, Raychem Corp.
Consultant, Greylock Management Corp.
Director, Avid Technology pharmaceutical company

Ernest Mario
CEO, Alza Corp. pharmaceutical company